SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005040
Filing Date
2020-05-04
Accepted
2020-05-04 16:36:32
Documents
67
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20200331x10q.htm 10-Q 2192146
2 EX-10.3 knsa-20200331ex103918d7f.htm EX-10.3 338455
3 EX-31.1 knsa-20200331ex311ebadd9.htm EX-31.1 13102
4 EX-31.2 knsa-20200331ex312aaa16b.htm EX-31.2 11836
5 EX-32.1 knsa-20200331ex321903a35.htm EX-32.1 7110
6 EX-32.2 knsa-20200331ex32257cfd8.htm EX-32.2 7105
  Complete submission text file 0001558370-20-005040.txt   6980678

Data Files

Seq Description Document Type Size
7 EX-101.INS knsa-20200331.xml EX-101.INS 1014504
8 EX-101.SCH knsa-20200331.xsd EX-101.SCH 60036
9 EX-101.CAL knsa-20200331_cal.xml EX-101.CAL 41166
10 EX-101.DEF knsa-20200331_def.xml EX-101.DEF 266275
11 EX-101.LAB knsa-20200331_lab.xml EX-101.LAB 500158
12 EX-101.PRE knsa-20200331_pre.xml EX-101.PRE 400674
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 20845386
SIC: 2834 Pharmaceutical Preparations